These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33326055)

  • 1. Immunotherapy and vaccination against infectious diseases.
    Ebbers M; Hemmer CJ; Müller-Hilke B; Reisinger EC
    Wien Klin Wochenschr; 2021 Jul; 133(13-14):714-720. PubMed ID: 33326055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers.
    Buchwald UK; Pirofski L
    Curr Pharm Des; 2003; 9(12):945-68. PubMed ID: 12678861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of biologic response modifiers in infectious disease.
    Masihi KN; Schäfer H
    Infect Dis Clin North Am; 2011 Dec; 25(4):723-31. PubMed ID: 22054752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infectious diseases in the ambulatory care setting].
    Zanetti G
    Rev Med Suisse; 2005 Jan; 1(2):134, 136-9. PubMed ID: 15773214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial overview: Immunomodulation: Striking the right balance: using immunomodulators to target infectious diseases, cancer, and autoimmunity.
    Lavelle EC; McLachlan JB
    Curr Opin Pharmacol; 2018 Aug; 41():vii-ix. PubMed ID: 30139514
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract.
    Domenech M; Sempere J; de Miguel S; Yuste J
    Front Immunol; 2018; 9():2700. PubMed ID: 30515172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy for infectious diseases: challenges and prospects].
    Karaulov AV; Kaliuzhin OV
    Ter Arkh; 2013; 85(11):100-8. PubMed ID: 24432609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.
    Pennini ME; De Marco A; Pelletier M; Bonnell J; Cvitkovic R; Beltramello M; Cameroni E; Bianchi S; Zatta F; Zhao W; Xiao X; Camara MM; DiGiandomenico A; Semenova E; Lanzavecchia A; Warrener P; Suzich J; Wang Q; Corti D; Stover CK
    Nat Commun; 2017 Dec; 8(1):1991. PubMed ID: 29222409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crisis in infectious diseases: time for a new paradigm?
    Casadevall A
    Clin Infect Dis; 1996 Oct; 23(4):790-4. PubMed ID: 8909846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines and immunotherapy for staphylococcal infections.
    Patti JM
    Int J Artif Organs; 2005 Nov; 28(11):1157-62. PubMed ID: 16353122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory approaches for prevention and treatment of infectious diseases.
    Nijnik A
    Curr Opin Microbiol; 2013 Oct; 16(5):590-5. PubMed ID: 23870826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where are we with monoclonal antibodies for multidrug-resistant infections?
    McConnell MJ
    Drug Discov Today; 2019 May; 24(5):1132-1138. PubMed ID: 30853568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Immunomodulatory Activities of Schiff Base Complexes Depending on their Metal Conjugation.
    Ayaz F; Gonul İ; Demirbag B; Ocakoglu K
    Inflammation; 2019 Oct; 42(5):1878-1885. PubMed ID: 31267275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and future in vaccines, drug development, and immunomodulatory therapy.
    Kling HM; Nau GJ; Ross TM; Evans TG; Chakraborty K; Empey KM; Flynn JL
    Ann Am Thorac Soc; 2014 Aug; 11 Suppl 4(Suppl 4):S201-10. PubMed ID: 25148426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulators as an antimicrobial tool.
    Pirofski LA; Casadevall A
    Curr Opin Microbiol; 2006 Oct; 9(5):489-95. PubMed ID: 16931122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-bacterial monoclonal antibodies: next generation therapy against superbugs.
    Wang H; Chen D; Lu H
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):3957-3972. PubMed ID: 35648146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Biological Insights in the Immunomodulatory Effects of Mucosal Polybacterial Vaccines in Clinical Practice.
    Tejera-Alhambra M; Palomares O; Perez de Diego R; Diaz-Lezcano I; Sanchez-Ramon S
    Curr Pharm Des; 2016; 22(41):6283-6293. PubMed ID: 27573928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical research designs to study treatment effects for multidrug-resistant bacteria.
    Paul M; Scudeller L
    Clin Microbiol Infect; 2019 Aug; 25(8):929-931. PubMed ID: 31121323
    [No Abstract]   [Full Text] [Related]  

  • 20. Cationic antimicrobial peptides as potential new therapeutic agents in neonates and children: a review.
    Ashby M; Petkova A; Hilpert K
    Curr Opin Infect Dis; 2014 Jun; 27(3):258-67. PubMed ID: 24722240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.